<--- Back to Details
First PageDocument Content
Vision / Ophthalmology / Medicine / Visual system / Diabetes / Blindness / Macula of retina / Diabetic retinopathy / Macular edema / Retina / Fundus / Human eye
Date: 2015-07-10 15:16:59
Vision
Ophthalmology
Medicine
Visual system
Diabetes
Blindness
Macula of retina
Diabetic retinopathy
Macular edema
Retina
Fundus
Human eye

766 IEEE TRANSACTIONS ON MEDICAL IMAGING, VOL. 31, NO. 3, MARCH 2012 Automatic Assessment of Macular Edema From Color Retinal Images

Add to Reading List

Source URL: cvit.iiit.ac.in

Download Document from Source Website

File Size: 2,91 MB

Share Document on Facebook

Similar Documents

766  IEEE TRANSACTIONS ON MEDICAL IMAGING, VOL. 31, NO. 3, MARCH 2012 Automatic Assessment of Macular Edema From Color Retinal Images

766 IEEE TRANSACTIONS ON MEDICAL IMAGING, VOL. 31, NO. 3, MARCH 2012 Automatic Assessment of Macular Edema From Color Retinal Images

DocID: 1qUNF - View Document

Micropulse laser for macular edema  p r i n c i p l e s , n e w pa r a m e t e r s a n d r e s u lt s w i t h 577 n m Frédéric Hamon MD 1

Micropulse laser for macular edema p r i n c i p l e s , n e w pa r a m e t e r s a n d r e s u lt s w i t h 577 n m Frédéric Hamon MD 1

DocID: 1mcPc - View Document

Current Eye Research 2001, Vol. 22, No. 2, pp. 140–$16.00 © Swets & Zeitlinger

Current Eye Research 2001, Vol. 22, No. 2, pp. 140–$16.00 © Swets & Zeitlinger

DocID: 1l9Ch - View Document

September 16, 2014  EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by yea

September 16, 2014 EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by yea

DocID: 1cqc9 - View Document

MACULART meeting PARISFIRST ANNOUNCEMENTJUNE 2015

MACULART meeting PARISFIRST ANNOUNCEMENTJUNE 2015

DocID: 1auUM - View Document